NCT02959086 Shanghai Epidemiology Study for Adolescents and Children with Cancer
| NCT ID | NCT02959086 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Cancer Group, China |
| Condition | Childhood Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2002-01 |
| Primary Completion | 2017-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2002-01 with a primary completion date of 2017-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.
Eligibility Criteria
Inclusion Criteria: * 0-19 year-old children and adolescents. * Diagnosed cancer in Shanghai since January 2002. Exclusion Criteria: * Patients who were lost of follow-up. * Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.
Contact & Investigator
Yi-Jin Gao, MD
PRINCIPAL INVESTIGATOR
Shanghai Children's Medical Center
Frequently Asked Questions
Who can join the NCT02959086 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 19 Years, studying Childhood Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02959086 currently recruiting?
Yes, NCT02959086 is actively recruiting participants. Contact the research team at gaoyijin@scmc.com.cn for enrollment information.
Where is the NCT02959086 trial being conducted?
This trial is being conducted at Shanghai, China, Shanghai, China.
Who is sponsoring the NCT02959086 clinical trial?
NCT02959086 is sponsored by Children's Cancer Group, China. The principal investigator is Yi-Jin Gao, MD at Shanghai Children's Medical Center. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.